Insider Selling: Neuralstem Insider Unloads 6,000 Shares of Stock (CUR)
Neuralstem (NYSE:CUR) Insider Karl Johe unloaded 6,000 shares of Neuralstem stock in a transaction that occurred on Tuesday, July 1st. The stock was sold at an average price of $4.17, for a total value of $25,020.00. Following the transaction, the insider now directly owns 490,247 shares in the company, valued at approximately $2,044,330. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
Shares of Neuralstem (NYSE:CUR) opened at 3.86 on Thursday. Neuralstem has a 52 week low of $1.30 and a 52 week high of $4.81. The stock’s 50-day moving average is $4.17 and its 200-day moving average is $3.68. The company’s market cap is $334.9 million.
Neuralstem (NYSE:CUR) last issued its quarterly earnings data on Monday, May 12th. The company reported ($0.07) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.06) by $0.01. The company had revenue of $0.00 million for the quarter, compared to the consensus estimate of $0.35 million. Analysts expect that Neuralstem will post $-0.25 EPS for the current fiscal year.
CUR has been the subject of a number of recent research reports. Analysts at Zacks reiterated an “outperform” rating on shares of Neuralstem in a research note on Wednesday, June 25th. They now have a $7.00 price target on the stock. Separately, analysts at Aegis raised their price target on shares of Neuralstem from $6.00 to $7.00 in a research note on Wednesday, June 25th. They now have a “buy” rating on the stock. Finally, analysts at Aegis raised their price target on shares of Neuralstem to $6.00 in a research note on Tuesday, May 27th.
Neuralstem, Inc is a development-stage company focused on the development and commercialization of treatments for central nervous system disease based on transplanting human neural stems cells and the use of small molecule drugs.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.